毛细支气管炎是婴幼儿住院的一个重要原因,属于一种婴幼儿较常见的下呼吸道感染,通常被认为是哮喘的第一次发作,与哮喘有着密切的关系,但其主要机制仍不清楚。近年来婴幼儿毛细支气管炎转变为哮喘的机制有较大进展,主要集中在免疫学领域。本文就近年免疫学方面的进展进行综述,以期为基础研究和临床诊疗提供参考。
Abstract
Bronchiolitis,a common lower respiratory tract infection in infants,is a major cause of infant hospitalization.Also,bronchiolitis is often considered the first attack of asthma,and has a close relationship with asthma,but its mechanism is still not clear.In recent years,the change of capillary bronchitis in infants and young children has a great progress,mainly in the field of immunology.This article reviews the progress of imm-unology in recent years,in order to provide reference for basic research and clinical diagnosis and treatment.
关键词
毛细支气管炎 /
哮喘 /
免疫 /
细胞因子
Key words
bronchiolitis /
asthma /
immune /
cell factor
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] Midulla F,Pierangeli A,Cangiano G,et al.Rhinovirus bionchiolitis and recurrent wheezing:1-year follow-up[J].Eur respir,2012,39(2):396-402.
[2] Omari K E,Dhaliwal B,Ren J,et al.Structures of respiratory syncytial virus nucleocapsid protein from two crystal forms:details of potential packing interactions in the native helical form[J].Acta Crystallogr Sect F Struct Biol Cryst Commun,2011,67(10):1179-1183.
[3] 宋文秀,何月贤,赵维笑.LTC4S基因多态性与呼吸道合胞病毒毛细支气管炎的相关性[J].广东医学,2015,36(9):1380-1383.
[4] 顾坚,雷尚兵,张仕超,等.干扰素联合雾化吸入对毛细支气管炎患儿肺功能的影响[J].浙江临床医学,2014,16(5):735-736.
[5] Carbonellestrany X,Simes EA,Dagan R,et al.Motavizumab for prophylaxis of respiratory syncytial virus in high-risk children:a noninferiority trial [J].Pediatrics,2010,125(1):e35-e51.
[6] 周晓英.孟鲁司特钠治疗婴幼儿毛细支气管炎的疗效及对反复喘息的预防效果[J].中国临床药学杂志,2011(3):157-159.
[7] Han RF,Li HY,Wang JW,et al.Study on clinical effect and immunologic mechanism of infants capillary bronchitis secondary bronchial asthma treated with bacterial lysates Broncho-Vaxom[J].Eur Rev Med Pharmaco,2016,20(10):2151-2155.
[8] 平雯,章建伟,钟永兴.孟鲁司特钠对毛细支气管炎后喘息的治疗及预防作用[J].中国现代医生,2013,51(25):156-157.
[9] Zaid AN,Abualhasan MN,Watson DG,et al.Investigation of the bioequivalence of montelukast chewable tablets after a single oral administration using a validated LC-MS/MS method[J].Drug Des Devel Ther,2015,23(9):5315-5321.
[10] O'Shea JJ,Plenge R.JAK and STAT signaling molecules in immunoregulation and immune-mediated disease[J].Immunity,2012,36(4):542-550.
[11] Wang J,Wu J,Kong L,et al.BuShenYiQi Formula strengthens Th1 response and suppresses Th2-Th17 responses in RSV-induced asthma exacerbated mice[J].J Ethnopharmacol,2014,154(1):131-147.
[12] Zhang G,Zhou KF,Lu ZH.Interleukin-17 enhances the removal of respiratory syncytial virus in mice by promoting neutrophill migration and reducing interferon-gamma expression[J].Genet Mol Res,2016,15(1).doi:10.4238/gmr.15017002
[13] Mukherjee S,Lindell DM,Berlin AA,et al.IL-17-induced pulmonary pathogenesis during respiratory viral infection and exacerbation of allergic disease[J].Am J Pathol,2011,179(1):248-258.
[14] Cautivo KM,Bueno SM,Cortes CM,et al.Efficient lung recruitment of respiratory syncytial virus-specific Th1 cells induced by recombinant bacillus Calmette-Guérin promotes virus clearance and protects from infection [J].J Immunol,2010,185(12):7633-7645. [15] Faber TE,Groen H,Welfing M,et al.Specific increase in local IL-17 production during recovery from primary RSV bronchiolitis[J].J Med Virol,2012,84(7):1084-1088.
[16] Bystrom J,Amin K,Bishop-Bailey D.Analysing the eosinophil cationic protein-a clue to the function of the eosinophil granulocyte[J].Respiratory Research,2011,12(1):1-20.
[17] Choi J,Callaway Z,Kim HB,et al.The role of TNF-α in eosinophilic inflammation associated with RSV bronchiolitis [J].Pediatric Allergy & Immunology,2010,21(3):474-479.
PDF(618 KB)
